These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19008150)

  • 1. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 2. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG
    J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
    Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
    Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
    [No Abstract]   [Full Text] [Related]  

  • 4. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endpoints for lymphatic filariasis programs.
    Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
    Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
    Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
    J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filariasis elimination, Zanzibar.
    Wkly Epidemiol Rec; 2001 Dec; 76(51-52):406-8. PubMed ID: 11789061
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
    Mukhopadhyay AK
    J Vector Borne Dis; 2010 Mar; 47(1):55-7. PubMed ID: 20231775
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albendazole for mass drug administration to eliminate lymphatic filariasis.
    Sabesan S
    Lancet Infect Dis; 2006 Nov; 6(11):684-5. PubMed ID: 17067916
    [No Abstract]   [Full Text] [Related]  

  • 19. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic filariasis: constraints ahead.
    Mishra CP; Singh N
    Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.